Lv3
310 积分 2023-10-11 加入
Utilizing ctDNA to discover mechanisms of resistance to targeted therapies in patients with metastatic NSCLC: towards more informative trials
1天前
已完结
A Large-Scale Prospective Concordance Study of Plasma- and Tissue-Based Next-Generation Targeted Sequencing for Advanced Non–Small Cell Lung Cancer (LC-SCRUM-Liquid)
2天前
已完结
Utilizing ctDNA to discover mechanisms of resistance to targeted therapies in patients with metastatic NSCLC: towards more informative trials
9天前
已完结
Early real-world experience monitoring circulating tumor DNA in resected early-stage non–small cell lung cancer
4个月前
已完结
Cerebrospinal fluid circulating tumor DNA profiling for risk stratification and matched treatment of central nervous system metastases
5个月前
已完结
[Correlation between common driver gene variations and clinicopathological typing in lung adenocarcinoma]
10个月前
已完结
[Clinicopathological analysis of 4 cases of lung cancer with concomitant EGFR mutation and ROS1 fusion]
10个月前
已完结
Interlesional response heterogeneity is associated with the prognosis of abiraterone treatment in metastatic castration-resistant prostate cancer
11个月前
已完结
Safety, Efficacy and Biomarker Analysis of Crizotinib in MET Mutated Non-Small Cell Lung Cancer – Results from the Drug Rediscovery Protocol
11个月前
已完结
Brief Report: Osimertinib Plus Capmatinib for Patients with MET-Altered EGFR-Mutant NSCLC following progression on front line therapy
11个月前
已关闭
皖公网安备34019202002308
